Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20660830

Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Aug 20
First author
London WB

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Aug 20;28(24):3800-2. doi: 10.1200/JCO.2010.30.0442.
    note
    Source null
    related pmid
    20660828
    relationship
    Comment in

Authors and identifiers

  1. name
    London WB
    type
    Author
  2. name
    Frantz CN
    type
    Author
  3. name
    Campbell LA
    type
    Author
  4. name
    Seeger RC
    type
    Author
  5. name
    Brumback BA
    type
    Author
  6. name
    Cohn SL
    type
    Author
  7. name
    Matthay KK
    type
    Author
  8. name
    Castleberry RP
    type
    Author
  9. name
    Diller L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    London WB
    type
    Author
  2. name
    Frantz CN
    type
    Author
  3. name
    Campbell LA
    type
    Author
  4. name
    Seeger RC
    type
    Author
  5. name
    Brumback BA
    type
    Author
  6. name
    Cohn SL
    type
    Author
  7. name
    Matthay KK
    type
    Author
  8. name
    Castleberry RP
    type
    Author
  9. name
    Diller L
    type
    Author
bibliography ids
  1. nci-bib-1994d9392cc118fbb9d59030
book metadata
content sha256
cd4477ae026d80a893ce643b8b171c4c8bd86b3200dcbf5df5949b4efb45a036
document type
citation
dois
  1. 10.1200/JCO.2009.27.5016
electronic publication date
display
2010 Jul 26
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20660830
immutable id
pubmed:20660830@cd4477ae026d80a893ce643b8b171c4c8bd86b3200dcbf5df5949b4efb45a036
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
24
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3808-15
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Aug 20;28(24):3800-2. doi: 10.1200/JCO.2010.30.0442.
    note
    Source null
    related pmid
    20660828
    relationship
    Comment in
outcomes validated
false
pmid
20660830
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
7d152334128097c961285834843f3a2339142482626a6cc3c76bcf32573970df
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Aug 20
precision
day
year
2010
publication types
  1. Clinical Trial, Phase II
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20660830/
title
Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study.

Preserved source evidence · Not medical advice